3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Lung Neoplasms
16
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
6
Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Fatigue
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Skin Carcinoma
2
Papillomavirus Infections
2
Malignant Solid Neoplasm
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Gastrointestinal Neoplasms
2
Interventions
Gemcitabine
16
Mitomycin
10
Docetaxel
6
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Educational Status
×
1 year
×
Clear all
No trials found.